home / stock / knsa / knsa message board
Subject | By | Source | When |
---|---|---|---|
znewcar1: KNSA 22% v1,2M c12.73 f68,5M H13.55 | znewcar1 | investorshangout | 11/01/2021 10:46:33 PM |
No bueno. I guess $HGEN's lenzilumab is | DonDonDonDon | investorshub | 04/01/2021 11:24:49 PM |
It was recently discovered that the protein GM-CSF | DonDonDonDon | investorshub | 03/22/2021 2:17:19 PM |
PT= $30-40 (by or around March 31st) | Femto99 | investorshub | 02/26/2021 11:28:28 PM |
PDUFA Mar21 | Femto99 | investorshub | 02/10/2021 6:44:09 PM |
News, Short Squeeze, Breakout and More Instantly...
Kiniksa Pharmaceuticals Ltd. Company Name:
KNSA Stock Symbol:
NASDAQ Market:
HAMILTON, Bermuda, May 07, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) today announced that management will participate...
HAMILTON, Bermuda, May 07, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Bank of America Securities 2024 Healthcare Conference on Tuesday, May 14, 2024 at 10:40 a.m. Pacific Time (1:40 p.m. East...
– ARCALYST ® (rilonacept) Q1 2024 net product revenue of $78.9 million, representing 85% year-over-year growth – – ARCALYST 2024 expected net product revenue increased to $370 - $390 million – – Abiprubart Phase 2b trial in Sjög...